Lijun Qu

Dr. Lijun Qu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Pharmacognosy Magazine
Verified
Journal Article
Open access
QLQiao Lyu
Qiao Lyu
YQYuan Qu
Yuan Qu
JCJianfan Chen
Jianfan Chen
GCGuo Chen
Guo Chen
ZCZheng Chen
Zheng Chen
LQLijun Qu
Lijun Qu
Objectives: The primary aim of this study is to investigate the specific effects and mechanisms of ganoderic acid A (GAA) on castration-resistant prostate cancer (CRPC). Materials and Methods: We successfully established an androgen-independent prostate cancer cell line (LNCaP-AI). The LNCaP-AI cells demonstrated accelerated growth, elevated levels of androgen receptor and prostate-specific antigen (PSA), and resistance to the drug enzalutamide. Then, we administered LNCaP-AI cells with GAA or a control and determined the cell growth rate. Next, LNCaP-AI cells with and without GAA treatment were subjected to RNA-seq for mRNA sequencing. The genes were subjected to a Kyoto Encyclopedia of Genes and Genomes analysis. We also checked the expression levels of the targeted genes. Finally, normal LNCaP or LNCaP-AI cells were subcutaneously injected into nude mice to further confirm the effect of GAA. Results: Experiments showed that GAA effectively suppressed the growth rate, PSA secretion, migration, and invasion of LNCaP-AI cells. The results of a subsequent RNA-seq analysis identified the PI3K/AKT pathway as the key signaling pathway influenced by GAA. Notably, AKT and GSK-3β phosphorylation was decreased, and β-catenin protein levels were also lowered, as a result of GAA treatment. Moreover, we observed decreased activity in crucial genes, including c-Myc, Cyclin D1 , and MMP-2 , which play integral roles in CRPC development. Furthermore, GAA inhibited the tumorigenesis of LNCaP-AI cells in nude mice in vivo . Conclusion: GAA effectively suppresses the growth of androgen-independent cells by inhibiting the AKT/GSK-3β/β-catenin signaling pathway. These findings demonstrate the potential of GAA as a therapeutic candidate for CRPC.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZCZheng Chen
Zheng Chen
TQTao Qi
Tao Qi
XQXiao-Ping Qin
Xiao-Ping Qin
JWJue Wang
Jue Wang
ZHZhang-Sen Huang
Zhang-Sen Huang
YZYumin Zhuo
Yumin Zhuo
The small nucleolar RNA host gene 12 (SNHG12) has been reported to play an important role in the tumorigenesis and progression of PCa, but the functional underlying mechanism has not been studied clearly. We detected the expression level of SNHG12 in PCa tissues and matched adjacent normal tissues that were collected from 85 patients. Then, colony formation assays, MTT experiments, and flow cytometry were used to examine the effect of SNHG12 on proliferation, cell cycle distribution, and apoptosis of DU145 cells. Further, Transwell invasion assay was utilized to assess whether SNHG12 participates in PCa cell invasion and affects the secretion of VEGF secretion in DU145 cells. Finally, we investigated the effect of SNHG12 on tumor growth in vivo. We found that SNHG12 promoted cell proliferation and suppressed apoptosis in PCa cells, which suggests that SNHG12 is probably a novel PCa biomarker and therapy target of PCa.


14 August 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
QLQiao Lyu
Qiao Lyu
PLPing Li
Ping Li
ZYZhenXiong Ye
ZhenXiong Ye
JCJiaHui Chen
JiaHui Chen
FLFeng Luo
Feng Luo
LQLijun Qu
Lijun Qu
Objectives: Nucleotide metabolism in clear cell renal cell carcinoma (ccRCC) remains understudied. Elucidating its heterogeneous characteristics and key genes may provide new insights for prognostic assessment and targeted therapy. Methods: By integrating scRNA-seq with bulk RNA-seq data, we first screened for nucleotide metabolism-related genes (NMRGs) using five machine learning algorithms. NMRGs signature was then constructed using 101 machine learning algorithms to optimize clinical prognosis assessment. The selected NMRGs were subjected to GO functional annotation and KEGG pathway enrichment analysis. Finally, the functional role of the key gene IFI30 was validated through both in vitro and in vivo experiments. Results: The NMRG signature constructed using 101 machine learning algorithms outperformed traditional clinical parameters and 122 published models across multiple independent cohorts. High-risk patients exhibited significantly worse overall survival. Enrichment analysis showed that IFI30 and its associated genes were significantly enriched in nucleotide metabolism pathways. Immunohistochemistry confirmed high IFI30 expression in ccRCC tumor tissues. Functional assays demonstrated that IFI30 knockdown suppressed ccRCC cell proliferation, migration, invasion, and tumorigenicity, while inducing apoptosis. In addition, IFI30 knockdown downregulated PRPS1/2, a key rate-limiting enzyme in nucleotide synthesis, and nucleotide rescue experiments reversed the phenotypic suppression, confirming that IFI30 promotes ccRCC progression through nucleotide metabolism. Conclusion: This study developed an NMRGs signature that outperforms existing models and, for the first time, reveals that IFI30 promotes ccRCC malignant progression by regulating nucleotide metabolism. These findings provide a new theoretical basis for prognostic assessment and metabolism-targeted therapy in ccRCC.